Mitomycin 5 mg/10mL (Mitomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 5 mg/10mL

Mitomycin 5 mg/10mL is a lyophilized powder for solution, used for intravenous administration. This medication is commonly associated with certain cancer treatments and is manufactured by Accord Healthcare, Inc.

Strength

5 mg/10mL

Pack Size

1 VIAL in 1 CARTON (16729-115-05) / 10 mL in 1 VIAL

Manufacturer / TM Owner

Accord Healthcare, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mitomycin is primarily used in the treatment of various types of cancer. It works by interfering with the growth of cancer cells, making it a key component in certain chemotherapy regimens. The specific uses of Mitomycin can vary depending on the type and stage of cancer being treated.

Side Effects

Common effects of Mitomycin may include nausea, vomiting, and fatigue. Some individuals may also experience hair loss and a decreased appetite. These effects can vary in severity and duration depending on the individual and the dosage administered.

Precautions & Warnings

Mitomycin should be handled with care, as it is a potent medication. It is important to follow the instructions provided by a healthcare professional when preparing and administering this medication. Proper disposal of any unused medication is also crucial to ensure safety.

Avoid Interactions

Mitomycin may interact with other medications, including certain antibiotics and other chemotherapy drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be avoided while using Mitomycin.

Frequently Asked Questions

Mitomycin is primarily used in the treatment of various types of cancer, often as part of a chemotherapy regimen.

Mitomycin is administered intravenously after being reconstituted as a solution from its lyophilized powder form.

Common side effects may include nausea, vomiting, fatigue, hair loss, and decreased appetite.

Mitomycin may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Mitomycin should be stored according to the manufacturer's instructions, typically in a cool, dry place away from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.